Clinical application of ultrasound-guided percutaneous microwave ablation in the treatment of T1aN0M0 stage renal carcinoma
- 28 Downloads
Evaluation of clinical application of ultrasound-guided percutaneous microwave ablation treatment for T1a renal carcinoma.
Analysis of the clinical data from 31 patients with T1aN0M0 stage renal carcinoma who underwent ultrasound-guided percutaneous microwave ablation in the Department of Ultrasound of China-Japan Union Hospital of Jilin University between March 2010 and June 2014.
All of the 31 patients were treated with ablation only once: 96.8% (30/31) of patients had no local recurrence or distant metastasis after ablation. One (3.2%) patient had local tumor recurrence 6 months after surgery and underwent a second microwave ablation. According to the results of 2 years of follow-up re-examinations, no further recurrence or distant metastasis was found. Moreover, 90.3% (28/31) of the patients had no complications with normal ranges of preoperative and postoperative serum creatinine and urea nitrogen levels. Complications were found in 9.7% (3/31) of the patients: one case of transient hematuria, one case of perirenal hematoma, and one case of cholecystitis; the symptoms were resolved with symptomatic treatment.
Ultrasound-guided percutaneous microwave ablation is a safe and effective micro-invasive therapy for T1a renal cancer patients.
KeywordsUltrasound-guided Microwave Ablation Kidney cancer
This study was funded by the Finance Department of Jilin Province (No. SCZSY201618).
Compliance with ethical standards
This study was conducted in accordance with the declaration of Helsinki. This study was conducted with approval from the Ethics Committee of Jilin University. Written informed consent was obtained from all participants.
Conflict of interest
The authors declare that they have no conflicts of interest.
- 4.Dunnick NR. Renal cell carcinoma: staging and surveillance. AbdomRadiol (NY). 2016;41:1079–85.Google Scholar
- 11.Lin Y, Liang P, Yu XL, et al. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with renal dysfunction. Int J Hyperthermia. 2016;15:1–6.Google Scholar